
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5827841
[patent_doc_number] => 20060063161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Detecting RNAi using SELDI mass spectrometry'
[patent_app_type] => utility
[patent_app_number] => 10/948028
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12612
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10948028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/948028 | Detecting RNAi using SELDI mass spectrometry | Sep 21, 2004 | Abandoned |
Array
(
[id] => 5041156
[patent_doc_number] => 20070093438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/572004
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 19085
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572004 | Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases | Sep 14, 2004 | Issued |
Array
(
[id] => 7116699
[patent_doc_number] => 20050070000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase'
[patent_app_type] => utility
[patent_app_number] => 10/938661
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15744
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938661 | Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase | Sep 12, 2004 | Abandoned |
Array
(
[id] => 7208512
[patent_doc_number] => 20050053583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method of inhibiting prion protein'
[patent_app_type] => utility
[patent_app_number] => 10/926011
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4776
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053583.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926011 | Method of inhibiting prion protein | Aug 25, 2004 | Abandoned |
Array
(
[id] => 6952841
[patent_doc_number] => 20050227936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923475
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 69417
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923475 | RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA) | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7138051
[patent_doc_number] => 20050182009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923201
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 69163
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182009.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923201
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923201 | RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA) | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7233131
[patent_doc_number] => 20050256068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/923451
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 65266
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923451 | RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA) | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7083172
[patent_doc_number] => 20050048552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Higher order structure and binding of peptide nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 10/909914
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 27934
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909914
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909914 | Higher order structure and binding of peptide nucleic acids | Aug 1, 2004 | Abandoned |
Array
(
[id] => 5386414
[patent_doc_number] => 20090227659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Nucleolar targeting of therapeutics against HIV'
[patent_app_type] => utility
[patent_app_number] => 10/902145
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9024
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902145 | Nucleolar targeting of therapeutics against HIV | Jul 29, 2004 | Abandoned |
Array
(
[id] => 5767478
[patent_doc_number] => 20060019258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods and compositions for detection of small interfering RNA and micro-RNA'
[patent_app_type] => utility
[patent_app_number] => 10/894969
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17324
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019258.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894969
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894969 | Methods and compositions for detection of small interfering RNA and micro-RNA | Jul 19, 2004 | Abandoned |
Array
(
[id] => 352361
[patent_doc_number] => 07491381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Method of evaluating compound efficacious in treating obesity'
[patent_app_type] => utility
[patent_app_number] => 10/564311
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14917
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564311 | Method of evaluating compound efficacious in treating obesity | Jul 8, 2004 | Issued |
Array
(
[id] => 5656489
[patent_doc_number] => 20060142225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 10/881580
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 59213
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881580 | RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA) | Jun 29, 2004 | Abandoned |
Array
(
[id] => 423826
[patent_doc_number] => RE039850
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2007-09-18
[patent_title] => 'Inhibitors of histone deacetylase'
[patent_app_type] => reissue
[patent_app_number] => 10/880444
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30235
[patent_no_of_claims] => 157
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10880444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/880444 | Inhibitors of histone deacetylase | Jun 28, 2004 | Issued |
Array
(
[id] => 5216027
[patent_doc_number] => 20070105108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Polynucleotides capable of target-depedent circularization and topological linkage'
[patent_app_type] => utility
[patent_app_number] => 10/561691
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24987
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561691
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561691 | Polynucleotides capable of target-depedent circularization and topological linkage | Jun 24, 2004 | Abandoned |
Array
(
[id] => 7211338
[patent_doc_number] => 20050053981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini'
[patent_app_type] => utility
[patent_app_number] => 10/872106
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32494
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053981.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872106 | Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini | Jun 17, 2004 | Abandoned |
Array
(
[id] => 5027931
[patent_doc_number] => 20070269378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Nadks as Modifiers of Branching Morphogenesis and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 10/556440
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16746
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556440 | Nadks as Modifiers of Branching Morphogenesis and Methods of Use | Jun 17, 2004 | Abandoned |
Array
(
[id] => 34027
[patent_doc_number] => 07786290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Double-stranded ribonucleic acid with increased effectiveness in an organism'
[patent_app_type] => utility
[patent_app_number] => 10/560336
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33054
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786290.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560336 | Double-stranded ribonucleic acid with increased effectiveness in an organism | Jun 13, 2004 | Issued |
Array
(
[id] => 7239573
[patent_doc_number] => 20050080246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Compositions comprising alternating 2\'-modified nucleosides for use in gene modulation'
[patent_app_type] => utility
[patent_app_number] => 10/860265
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55889
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860265 | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation | Jun 2, 2004 | Issued |
Array
(
[id] => 7127300
[patent_doc_number] => 20050059044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Double-stranded nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 10/861191
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 33528
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861191 | Double-stranded nucleic acid | Jun 2, 2004 | Abandoned |
Array
(
[id] => 142067
[patent_doc_number] => 07691821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Inhibition of SHIP to enhance stem cell harvest and transplantation'
[patent_app_type] => utility
[patent_app_number] => 10/709801
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 5509
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10709801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/709801 | Inhibition of SHIP to enhance stem cell harvest and transplantation | May 27, 2004 | Issued |